Our Impact
We are already making a big impact
Poised to be the go-to solution to collect and certify discarded medication
Congress has called for refunds for discarded medications
H.R.3684 — 117th Congress Infrastructure Bill calls for refunds
Section 90004 - REQUIRING MANUFACTURERS OF CERTAIN SINGLE-DOSE CONTAINER OR SINGLE-USE PACKAGE DRUGS PAYABLE UNDER PART B OF THE MEDICARE PROGRAM TO PROVIDE REFUNDS WITH RESPECT TO DISCARDED AMOUNTS OF SUCH DRUGS
Legislation
Legislative impact
Active engagement with Government entities
We have worked closely with government entities to advance change since our inception
Modifications to government reimbursement model
Revert proposed modifications that resulted in the incorporation of authored language included in the 2020 Omnibus Appropriations Bill
Center for Medicare & Medicaid Innovation (CMMI): CMMI Pilot
Revert submitted a pilot proposal request to CMMI that included an estimated $840 million in savings to the U.S. government within 1-year of operation
Proposal to Appropriations Committees to fund pilot in Medicare Part D
Revert led recent discussions with appropriations committees in both the Senate and the House
Alignment to Health and Human Services (HHS) mission to optimize technology in healthcare
Proof-of-concept studies have uncovered >$30M in waste to date
Proof of Concept
In 2018, Dr. Okuda conducted a one-year pilot with two studies to collect wasted specialty medications for multiple sclerosis
Two Institutional Review Board (IRB)-approved studies at the Clinical Center for Multiple Sclerosis at The University of Texas Southwestern Medical Center in Dallas, Texas.
1-year study of recovered DMTs
Passive effort utilized patient response to flyers posted in MS Clinic
422 Patients
$12,210 Waste/overage per patient
$5.2M Total collected (average wholesale price)
30-day study of recovered DMTs
Active effort utilized proactive request from MS provider
49 Patients
~$22,450 Waste/overage per patient
>$1M Total collected (average wholesale price)
As of 2023, Revert has identified an additional $30M in wasted DMTs from one multiple sclerosis clinic
Publications & Press
Revert In The News
Read about our research into the magnitude of unused specialty medications in MS
Publications
“Hiding in plain sight: The magnitude of unused disease modifying therapies in multiple sclerosis and strategies for reducing the economic burden of care”
Publications from Darin T. Okuda, MD
Soundbytes
“The Wide-Reaching Impact of Multiple Sclerosis DMT Waste: Darin T. Okuda, MD; Karin Cook”
